ACCESS AND INFORMATION AGREEMENTAccess and Information Agreement • June 25th, 2014 • rEVO Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 25th, 2014 Company Industry JurisdictionThis Access and Information Agreement (the “Agreement”) is effective as of June 25, 2014, by and between Laboratoire français du Fractionnement et des Biotechnologies, a French Corporation (“LFB”), and rEVO Biologics, Inc., a Delaware corporation (the “Company,” with each of LFB and the Company a “Party” and together, the “Parties”).